Citius Pharmaceuticals

15.08.2018

ZAG-S&W represented H.C. Wainwright, as underwriter, in Citius Pharmaceuticals’ (NASDAQ: CTXR) $10 million offering of common stock, warrants and prefunded units.

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously-approved active pharmaceutical ingredients.

The ZAG-S&W team was led by Oded Har-Even and Robert Condon.

Recent Activity